DE19821039A1 - Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan - Google Patents
Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonanInfo
- Publication number
- DE19821039A1 DE19821039A1 DE19821039A DE19821039A DE19821039A1 DE 19821039 A1 DE19821039 A1 DE 19821039A1 DE 19821039 A DE19821039 A DE 19821039A DE 19821039 A DE19821039 A DE 19821039A DE 19821039 A1 DE19821039 A1 DE 19821039A1
- Authority
- DE
- Germany
- Prior art keywords
- diazabicyclo
- benzyl
- nonane
- mixture
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- AFYZAHZKOFBVLE-UONOGXRCSA-N (4as,7as)-6-benzyl-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridine Chemical compound C([C@H]1NCCC[C@H]1C1)N1CC1=CC=CC=C1 AFYZAHZKOFBVLE-UONOGXRCSA-N 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 title description 3
- 230000003115 biocidal effect Effects 0.000 title description 2
- 229960003702 moxifloxacin Drugs 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 77
- 239000000203 mixture Substances 0.000 claims abstract description 44
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract description 38
- AFYZAHZKOFBVLE-KGLIPLIRSA-N (4ar,7ar)-6-benzyl-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridine Chemical compound C([C@@H]1NCCC[C@@H]1C1)N1CC1=CC=CC=C1 AFYZAHZKOFBVLE-KGLIPLIRSA-N 0.000 claims abstract description 27
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000001358 L(+)-tartaric acid Substances 0.000 claims abstract description 24
- 235000011002 L(+)-tartaric acid Nutrition 0.000 claims abstract description 24
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 54
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 239000011877 solvent mixture Substances 0.000 claims description 20
- 229940095064 tartrate Drugs 0.000 claims description 19
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000001953 recrystallisation Methods 0.000 claims description 10
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 9
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000011081 inoculation Methods 0.000 claims description 4
- KSCPLKVBWDOSAI-NKWVEPMBSA-N (4as,7as)-2,3,4,4a,5,6,7,7a-octahydro-1h-pyrrolo[3,4-b]pyridine Chemical compound N1CCC[C@H]2CNC[C@H]21 KSCPLKVBWDOSAI-NKWVEPMBSA-N 0.000 claims description 3
- JIMFXOQAQLUDKB-UHFFFAOYSA-N 7a-benzyl-1,2,3,4,4a,5,6,7-octahydropyrrolo[3,4-b]pyridine Chemical compound C1NCC(CCCN2)C12CC1=CC=CC=C1 JIMFXOQAQLUDKB-UHFFFAOYSA-N 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 239000013078 crystal Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 6
- QAPHOFIEVHTDAB-QYDSKQJFSA-N (4as,7as)-6-benzyl-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridine;(2r,3r)-2,3-dihydroxybutanedioic acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O.C([C@H]1NCCC[C@H]1C1)N1CC1=CC=CC=C1 QAPHOFIEVHTDAB-QYDSKQJFSA-N 0.000 description 5
- DJWOBYLOYYIQRM-UHFFFAOYSA-N 2-benzyl-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-b]pyridine Chemical compound C=1C=2NCCCC=2NC=1CC1=CC=CC=C1 DJWOBYLOYYIQRM-UHFFFAOYSA-N 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 4
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- AUONNNVJUCSETH-UHFFFAOYSA-N icosanoyl icosanoate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCC AUONNNVJUCSETH-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- AFYZAHZKOFBVLE-UHFFFAOYSA-N 6-benzyl-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridine Chemical class C1C2CCCNC2CN1CC1=CC=CC=C1 AFYZAHZKOFBVLE-UHFFFAOYSA-N 0.000 description 1
- LXNXRHQZTQKKGO-FXSGNONSSA-N 7-[(4as,7as)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-3,4-dioxo-2h-quinoline-2-carboxylic acid Chemical compound C1=2C(OC)=C(N3C[C@H]4NCCC[C@H]4C3)C(F)=CC=2C(=O)C(=O)C(C(O)=O)N1C1CC1 LXNXRHQZTQKKGO-FXSGNONSSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- -1 benzylpyrrolopiperidine tartrate Chemical compound 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821039A DE19821039A1 (de) | 1998-05-11 | 1998-05-11 | Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan |
| JP2000548336A JP4554076B2 (ja) | 1998-05-11 | 1999-04-28 | （ｓ，ｓ）−ベンジル−２，８−ジアザビシクロ［４．３．０］ノナンの製造方法 |
| EP99920805A EP1077979B1 (de) | 1998-05-11 | 1999-04-28 | Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan |
| CA2331526A CA2331526C (en) | 1998-05-11 | 1999-04-28 | Purification of (s,s)-8-benzyl-2,8-diazabicyclo[4.3.o]nonane using l-(+) tartaric acid in alcohol/water solvent mixture |
| DE59912242T DE59912242D1 (de) | 1998-05-11 | 1999-04-28 | Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan |
| ES99920805T ES2245101T3 (es) | 1998-05-11 | 1999-04-28 | Procedimiento para la fabricacion de (s,s)-bencil-2,8-diazabiciclo(4.3.0.)nonano. |
| US09/700,107 US6235908B1 (en) | 1998-05-11 | 1999-04-28 | Method for producing (S,S)-benzyl-2,8-diazabicyclo[4.3.0]nonane |
| PCT/EP1999/002860 WO1999058532A1 (de) | 1998-05-11 | 1999-04-28 | Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo[4.3.0]nonan |
| AU38245/99A AU3824599A (en) | 1998-05-11 | 1999-04-28 | Method for producing (s,s)-benzyl-2,8-diazabicyclo{4.3.0}nonane |
| ARP990102026A AR019123A1 (es) | 1998-05-11 | 1999-04-30 | Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo[4.3.0]nonano |
| UY25501A UY25501A1 (es) | 1998-05-11 | 1999-05-07 | Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo [4.3.0]nonano |
| PE1999000379A PE20000477A1 (es) | 1998-05-11 | 1999-05-10 | Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo[4.3.0)nonano |
| CO99028729A CO4830459A1 (es) | 1998-05-11 | 1999-05-10 | Procedimiento para la preapracion de (s,s)-bencil-2,8- diazabicilo[4,3,0]nonano |
| SV1999000060A SV1999000060A (es) | 1998-05-11 | 1999-05-11 | Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821039A DE19821039A1 (de) | 1998-05-11 | 1998-05-11 | Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE19821039A1 true DE19821039A1 (de) | 1999-11-18 |
Family
ID=7867389
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19821039A Ceased DE19821039A1 (de) | 1998-05-11 | 1998-05-11 | Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan |
| DE59912242T Expired - Lifetime DE59912242D1 (de) | 1998-05-11 | 1999-04-28 | Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE59912242T Expired - Lifetime DE59912242D1 (de) | 1998-05-11 | 1999-04-28 | Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6235908B1 (https=) |
| EP (1) | EP1077979B1 (https=) |
| JP (1) | JP4554076B2 (https=) |
| AR (1) | AR019123A1 (https=) |
| AU (1) | AU3824599A (https=) |
| CA (1) | CA2331526C (https=) |
| CO (1) | CO4830459A1 (https=) |
| DE (2) | DE19821039A1 (https=) |
| ES (1) | ES2245101T3 (https=) |
| PE (1) | PE20000477A1 (https=) |
| SV (1) | SV1999000060A (https=) |
| UY (1) | UY25501A1 (https=) |
| WO (1) | WO1999058532A1 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009125425A3 (en) * | 2008-02-08 | 2009-12-03 | Neuland Laboratories Ltd | Improved process for the preparation of (s.s)-2.8-diazabicyclo[4.3.0]nonane |
| EP2679588A4 (en) * | 2011-10-14 | 2014-03-12 | Shanghai Puyi Chemical Technology Co Ltd | Asymmetric synthesis method, related raw material and preparation method of (s,s)-2,8-diazabicyclo[4,3,0]nonane |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE285821T1 (de) * | 1999-10-08 | 2005-01-15 | Affinium Pharm Inc | Fab i inhibitoren |
| US6476046B1 (en) | 2000-12-04 | 2002-11-05 | Sepracor, Inc. | Diazabicyclo[4.3.0]nonanes, and methods of use thereof |
| CA2444597A1 (en) * | 2001-04-06 | 2002-10-06 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
| EP1575951B1 (en) | 2002-12-06 | 2014-06-25 | Debiopharm International SA | Heterocyclic compounds, methods of making them and their use in therapy |
| DE602004016831D1 (de) | 2003-03-17 | 2008-11-13 | Affinium Pharm Inc | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend |
| EP2848614A3 (en) | 2004-06-04 | 2015-07-29 | Debiopharm International SA | Acrylamide derivatives as antibiotic agents |
| EP1973902A2 (en) * | 2005-12-05 | 2008-10-01 | Affinium Pharmaceuticals, Inc. | 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| EP2687533B1 (en) | 2006-07-20 | 2017-07-19 | Debiopharm International SA | Acrylamide derivatives as FAB I inhibitors |
| JP2010509305A (ja) * | 2006-11-13 | 2010-03-25 | シプラ・リミテッド | モキシフロキサシン塩酸塩の合成方法 |
| US7692015B2 (en) * | 2007-01-05 | 2010-04-06 | Zheqing Wang | Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer |
| WO2008098374A1 (en) | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
| IT1393337B1 (it) | 2009-03-06 | 2012-04-20 | Italiana Sint Spa | Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina |
| SI2861608T1 (sl) | 2012-06-19 | 2019-08-30 | Debiopharm International Sa | Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid |
| BR122023021456A2 (pt) | 2016-02-26 | 2024-02-20 | Debiopharm International S.A. | Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica |
| LT3923914T (lt) | 2019-02-14 | 2023-07-25 | Debiopharm International S.A. | Afabicino kompozicija, jos gamybos būdas |
| CN113939306B (zh) | 2019-06-14 | 2024-07-19 | 德彪药业国际股份公司 | 用于治疗涉及生物膜的细菌感染的药物及其用途 |
| CN112574197B (zh) * | 2020-12-07 | 2021-12-31 | 泰安汉威集团有限公司 | 一种化合物c的手性纯化方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0550903A1 (de) * | 1992-01-10 | 1993-07-14 | Bayer Ag | Chinolon- und Naphthyridon-Carbonsäurederivate als antibakterielles Mittel |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB354975A (en) * | 1929-07-19 | 1931-08-20 | Ig Farbenindustrie Ag | Manufacture of optically active phenylpropanol-methylamines |
| HU194221B (en) * | 1985-04-19 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound |
| JPH0285235A (ja) * | 1988-09-22 | 1990-03-26 | Kohjin Co Ltd | 光学活性アミノアルコール類の製法 |
| JP2995704B2 (ja) * | 1989-02-17 | 1999-12-27 | 東京化成工業株式会社 | 光学活性な１ｈ−３−アミノピロリジン化合物の製造法 |
| IT1231158B (it) * | 1989-07-20 | 1991-11-19 | Dompe Farmaceutici Spa | Procedimento per la risoluzione ottica della dropropizina. |
| DK0569387T3 (da) * | 1991-01-31 | 1995-07-03 | Pfizer | Optisk adskillelse af trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2H-pyrido/1,2-a/ pyrazin |
| DE4234078A1 (de) * | 1992-10-09 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
| DE4234330A1 (de) * | 1992-10-12 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
| NO301165B1 (no) * | 1992-12-25 | 1997-09-22 | Daiichi Seiyaku Co | Bicykliske aminderivater og antibakterielle midler inneholdende disse |
| US5686614A (en) * | 1995-04-11 | 1997-11-11 | Neurogen Corporation | Preparation of chiral 5-aminocarbonyl-5H-dibenzo a,d!cyclohepten-5,10-imines by optical resolution |
| DE19601745C1 (de) | 1996-01-19 | 1997-10-09 | Gruenenthal Gmbh | Verfahren zur Racematspaltung von Tramadol |
-
1998
- 1998-05-11 DE DE19821039A patent/DE19821039A1/de not_active Ceased
-
1999
- 1999-04-28 JP JP2000548336A patent/JP4554076B2/ja not_active Expired - Lifetime
- 1999-04-28 CA CA2331526A patent/CA2331526C/en not_active Expired - Lifetime
- 1999-04-28 AU AU38245/99A patent/AU3824599A/en not_active Abandoned
- 1999-04-28 DE DE59912242T patent/DE59912242D1/de not_active Expired - Lifetime
- 1999-04-28 WO PCT/EP1999/002860 patent/WO1999058532A1/de not_active Ceased
- 1999-04-28 EP EP99920805A patent/EP1077979B1/de not_active Expired - Lifetime
- 1999-04-28 US US09/700,107 patent/US6235908B1/en not_active Expired - Lifetime
- 1999-04-28 ES ES99920805T patent/ES2245101T3/es not_active Expired - Lifetime
- 1999-04-30 AR ARP990102026A patent/AR019123A1/es unknown
- 1999-05-07 UY UY25501A patent/UY25501A1/es not_active Application Discontinuation
- 1999-05-10 CO CO99028729A patent/CO4830459A1/es unknown
- 1999-05-10 PE PE1999000379A patent/PE20000477A1/es not_active Application Discontinuation
- 1999-05-11 SV SV1999000060A patent/SV1999000060A/es unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0550903A1 (de) * | 1992-01-10 | 1993-07-14 | Bayer Ag | Chinolon- und Naphthyridon-Carbonsäurederivate als antibakterielles Mittel |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009125425A3 (en) * | 2008-02-08 | 2009-12-03 | Neuland Laboratories Ltd | Improved process for the preparation of (s.s)-2.8-diazabicyclo[4.3.0]nonane |
| EP2679588A4 (en) * | 2011-10-14 | 2014-03-12 | Shanghai Puyi Chemical Technology Co Ltd | Asymmetric synthesis method, related raw material and preparation method of (s,s)-2,8-diazabicyclo[4,3,0]nonane |
Also Published As
| Publication number | Publication date |
|---|---|
| US6235908B1 (en) | 2001-05-22 |
| WO1999058532A1 (de) | 1999-11-18 |
| EP1077979B1 (de) | 2005-07-06 |
| JP4554076B2 (ja) | 2010-09-29 |
| AU3824599A (en) | 1999-11-29 |
| SV1999000060A (es) | 1999-10-27 |
| PE20000477A1 (es) | 2000-07-07 |
| ES2245101T3 (es) | 2005-12-16 |
| UY25501A1 (es) | 1999-11-17 |
| CA2331526A1 (en) | 1999-11-18 |
| CO4830459A1 (es) | 1999-08-30 |
| JP2002514648A (ja) | 2002-05-21 |
| DE59912242D1 (de) | 2005-08-11 |
| EP1077979A1 (de) | 2001-02-28 |
| AR019123A1 (es) | 2001-12-26 |
| CA2331526C (en) | 2011-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1077979B1 (de) | Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan | |
| DE60100321T2 (de) | Verfahren zur Herstellung von 11-Amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin und Anwendung zur Synthese von Thianeptin | |
| DE69522808T2 (de) | Verfahren zur herstellung von 2- (1-azabicyclo (2.2.2) oct-3-y)) -2,4,5,6-tetrahydro-1 h-benz (de) isochinolin-1-on und zwischenprodukte | |
| DE2541184C2 (de) | (+)- und (-)-N-(2-Benzhydryl-äthyl)-N-(1-phenyl-äthyl)-amine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
| EP1192153B1 (de) | Verfahren zur enantiomerentrennung von cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo 4.3.0]nonan | |
| CH695686A5 (de) | Verfahren zur Herstellung von Imidachloprid. | |
| DE1568277A1 (de) | Verfahren zur Herstellung von neuen,optisch aktiven Phenylisopylamin-Derivaten | |
| DE1768612A1 (de) | Verfahren zur Herstellung von sehr reinem,pharmazeutisch geeignetem rechtsdrehenden 2,2'-(AEthylendiimin)-di-1-butanoldihydrochlorid | |
| DE1285478B (de) | Verfahren zur Herstellung von neuen 5, 6, 7, 8-Tetrahydropyrido-[4, 3-d]pyrimidinen | |
| CH624673A5 (https=) | ||
| DE69804853T2 (de) | Verfahren zur herstellung von mequitazin und zwischenprodukt der synthese | |
| WO1993009780A1 (de) | Verwendung von sulfonylverbindungen | |
| DE2738643C2 (de) | Verfahren zur Herstellung von α-Cyano-3-phenoxy-benzylalkohol | |
| DE1670143C3 (https=) | ||
| DE1593782B2 (de) | 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate | |
| DE2824291A1 (de) | Neue benzylalkoholderivate und verfahren zu ihrer herstellung | |
| DE1543391C3 (de) | 1-(2-Nitrilophenoxy)-2-hydroxy-3isopropylaminopropan und dessen Salze | |
| DE1445138C (de) | Verfahren zur Herstellung von l-(2,3,4-Trimethoxybenzyi)-piperazin und Säureadditionssalzen davon | |
| DE1154120B (de) | Verfahren zur Herstellung von neuen Ajmalinderivaten | |
| DE19624604A1 (de) | Verfahren zur Herstellung chiraler, nicht racemischer (4-Aryl-2,5-dioxoimidazolidin-1-yl)essigsäuren | |
| AT282586B (de) | Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen | |
| CH581625A5 (en) | 2-dimethylallylbenzomorphans - analgesics | |
| DE1545946C3 (de) | (-)-2-Carbalkoxymethyl-3-alkyl-9, 10-dimethoxy-1,4,6,7-tetrahydro-11 bHbenzo eckige Klammer auf a eckige Klammer zu chinolizine und deren Salze sowie Verfahren zu ihrer Herstellung | |
| EP0704428A1 (de) | Verfahren zur Herstellung von Salcomin | |
| DE1593782C3 (de) | 1-Nitrilophenoxy- 2- hydroxy -3- tertbutylaminopropane, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8131 | Rejection |